In study involving 40 patients, high patient satisfaction was observed and no adverse events were recorded<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, June 5, 2023 (HealthDay News) — Magnetically controlled capsule endoscopy (MCCE) offers a high rate of visualization of all regions of the gastric mucosa and is associated with high patient satisfaction and no adverse events, according to a study published online June 1 in iGIE<\/em>.<\/p>\n Andrew C. Meltzer, M.D., from the George Washington University School of Medicine & Health Sciences in Washington, D.C., and colleagues conducted a single-arm comparative study involving adult patients aged 18 years and older who were referred for an esophagogastroduodenoscopy (EGD) as part of a standard evaluation for symptoms. Before the EGD, participants received MCCE. Two independent physicians reviewed the MCCE videos and compared them to subsequent EGD.<\/p>\n The researchers found that MCCE detected each of the six preidentified major gastric anatomic landmarks in this study of 40 patients, with a rate of visualization greater than 95 percent. A follow-up EGD was received by 35 patients; MCCE did not miss any high-risk lesions. Patients preferred MCCE to EGD (80 versus 13 percent); no adverse events occurred.<\/p>\n “A traditional endoscopy is an invasive procedure for patients, not to mention it is costly due to the need for anesthesia and time off work,” Meltzer said in a statement. “If larger studies can prove this method is sufficiently sensitive to detect high-risk lesions, magnetically controlled capsules could be used as a quick and easy way to screen for health problems in the upper gastrointestinal tract such as ulcers or stomach cancer.”<\/p>\n Two authors disclosed ties to medical technology companies, including AnX Robotica, which funded the study.<\/p>\n